SavedAdd your journal

Journals / International Journal of Health Services Research and Policy / 2023 / Cilt: 8 Sayı: 2

SEROPREVALENCE OF TRANSFUSION TRANSMISSIBLE INFECTIONS IN BLOOD DONORS OF A NEWLY ESTABLISHED TERTIARY CARE TEACHING HOSPITAL NEAR SUNDARBAN REGION OF WEST BENGAL

Sukla MITRA
Soumitra DAS
Santanu SAHA
Pages
93–99
Publication Date
2023-08-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion – Increase in public awareness regarding voluntary blood donation, meticulous donor screening and regular use of highly sensitive tests are essential to reduce the risk of TTIs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective – To study the socio-demographic profile of blood donors and to determine the seroprevalence of transfusion transmissible infections (TTIs) among them.
📊
Key Findings & Data:Materials and methods – It is a retrospective cross-sectional study for 3 years from January 2020 to December 2022.
💡
Conclusion & Impact:Conclusion – Increase in public awareness regarding voluntary blood donation, meticulous donor screening and regular use of highly sensitive tests are essential to reduce the risk of TTIs.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Blood bank · Blood donors · Seroprevalence

Abstract

Objective – To study the socio-demographic profile of blood donors and to determine the seroprevalence of transfusion transmissible infections (TTIs) among them. Materials and methods – It is a retrospective cross-sectional study for 3 years from January 2020 to December 2022. Records of the blood donors were collected from the blood bank of a tertiary care teaching hospital and were analyzed through epi info7 to find out the seroprevalence of TTIs. Results – Among the donors majority were male (76.74%) and 1.11% were found to be seropositive for TTIs. Seroprevalence was highest for hepatitis B (0.72%) followed by hepatitis C (0.18%), syphilis (0.13%) and least for human immunodeficiency virus (0.08%); however, no donor was found to be positive for malaria. Seropositivity was highest among the age group of 31-40 years of age (47.12%). Conclusion – Increase in public awareness regarding voluntary blood donation, meticulous donor screening and regular use of highly sensitive tests are essential to reduce the risk of TTIs.

🔖

Cite This Article

MITRA, S., DAS, S., SAHA, S. (2023). SEROPREVALENCE OF TRANSFUSION TRANSMISSIBLE INFECTIONS IN BLOOD DONORS OF A NEWLY ESTABLISHED TERTIARY CARE TEACHING HOSPITAL NEAR SUNDARBAN REGION OF WEST BENGAL. International Journal of Health Services Research and Policy, Cilt: 8 Sayı: 2, 93–99. https://ajindex.com/articles/959539

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Pallavi P., Ganesh C.K, JayashreeK., Manjunath G.V.,“Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study”,Indian J Hematol Blood Transfus, 27,1–6, 2011.
  2. Stramer S.L., Hollinger F.B., Katz L.M., Kleinman S., Metzel P.S., Gregory K.R., et al.,“Emerging infectious disease agents and their potential threat to transfusion safety”,Transfus, 49, 1S–29S,2009.
  3. Kitchen A.D., Barbara J.A.,Practical Transfusion Medicine, John Wiley &Sons Ltd., New York, 2001.
  4. Ataro Z., Urgessa F., Wasihun T.,“Prevalence and trends of major transfusion transmissible infections among blood donors in Dire Dawa blood bank, Eastern Ethiopia: Retrospective study”,Ethiop J Health Sci, 28(6),701–10, 2018.
  5. Shukla R.S., Bhuyan K.K.,“Can data on HIV sero-reactivity among blood donors provide an insight into HIV prevalence in the general population?”,Indian J Public Health, 51,14-21, 2007.
  6. Shrestha A.C., Ghimire P., Tiwari B.R., Rajkarnikar M., “Transfusion-transmissible infections among blood donors in Kathmandu, Nepal”, J Infect Dev Ctries, 3, 794-7, 2009. National AIDS Control Organization. Standards for Blood Banks and Blood Transfusion Services, New Delhi: Ministry of Health and Family Welfare Government of India,2007.
  7. Adhikary R., Bhavana M.V.,“The risk of transfusion transmissible infections. Where do we stand in 2018?”,Glob J Transfus Med, 3(2), 88, 2018.
  8. Sachan D., Varghese J., Joseph J., Srinivasan V., Jayanthi V., Rela M.,“HBsAg positive patient characteristics in hospital and blood donation camps”,ISRN Hematol, 675191, 2013.
  9. Narahari S., Juwle A., Basak S., Saranath D.,“Prevalence and geographic distribution of hepatitis C virus genotype in Indian patient cohort”,Infect Genet Evol, 9(4), 643–5, 2009.
  10. Meena G.C., Beelwal D., Tailor S.B., Sunaria R.K.,“Seroprevalence of transfusion transmissible infections among blood donors at a tertiary care teaching hospital in Ajmer, Rajasthan: a 5-year study”,Asian J Pharm Clin Res,15(9), 230-233, 2022.
  11. Giri P.A., Deshpande J.D., Phalke D.B., Karle L.B.,“Seroprevalence of transfusion transmissible infections among voluntary blood donors at a tertiary care teaching hospital in rural area of India”,J Family Med Prim Care, 1, 48-51, 2012.
  12. Tiwari B.R., Ghimmire P., Karki S., Rajkarnikar M.,“Seroprevalence of human immunodeficiency virus in Nepalese blood donors: A study from three regional blood transfusion services”,Asian J Transfus Sci, 2, 66-8, 2008.
  13. Bhawani Y., Rao P